- Home
- PTGX vs BCO Comparison
PTGX vs BCO Comparison
Compare PTGX & BCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- BCO
- Stock Information
- Founded
- PTGX 2006
- BCO 1859
- Country
- PTGX United States
- BCO United States
- Employees
- PTGX N/A
- BCO N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- BCO Oil Refining/Marketing
- Sector
- PTGX Health Care
- BCO Consumer Discretionary
- Exchange
- PTGX Nasdaq
- BCO Nasdaq
- Market Cap
- PTGX 3.3B
- BCO 3.6B
- IPO Year
- PTGX 2016
- BCO N/A
- Fundamental
- Price
- PTGX $51.07
- BCO $105.29
- Analyst Decision
- PTGX Strong Buy
- BCO Strong Buy
- Analyst Count
- PTGX 8
- BCO 1
- Target Price
- PTGX $70.13
- BCO $138.00
- AVG Volume (30 Days)
- PTGX 608.4K
- BCO 279.1K
- Earning Date
- PTGX 08-06-2025
- BCO 08-06-2025
- Dividend Yield
- PTGX N/A
- BCO 0.97%
- EPS Growth
- PTGX N/A
- BCO 24.94
- EPS
- PTGX 0.80
- BCO 3.72
- Revenue
- PTGX $209,180,000.00
- BCO $5,069,900,000.00
- Revenue This Year
- PTGX N/A
- BCO $3.91
- Revenue Next Year
- PTGX $53.09
- BCO $4.45
- P/E Ratio
- PTGX $63.42
- BCO $28.29
- Revenue Growth
- PTGX N/A
- BCO 2.17
- 52 Week Low
- PTGX $33.31
- BCO $80.10
- 52 Week High
- PTGX $60.60
- BCO $115.91
- Technical
- Relative Strength Index (RSI)
- PTGX 37.60
- BCO 73.96
- Support Level
- PTGX $52.03
- BCO $84.99
- Resistance Level
- PTGX $54.81
- BCO $94.55
- Average True Range (ATR)
- PTGX 2.11
- BCO 2.62
- MACD
- PTGX -0.52
- BCO 1.41
- Stochastic Oscillator
- PTGX 8.78
- BCO 98.31
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About BCO Brinks Company (The)
The Brink's Co is a provider of secure logistics and security solutions for cash and other valuables. Its segments include: North America segment includes operations in the U.S. and Canada, including the Brink's Global Services (BGS) line of business; Latin America segment consists operations in Latin American countries where it has an ownership interest, including the BGS line of business; Europe segment includes total operations in European countries that provide services outside of the BGS line of business; and Rest of World segment consists operations in the Middle East, Africa and Asia. It also includes total operations in European countries that provides BGS services and BGS activity in Latin American countries. It derives maximum revenue from North America segment.